Pfizer says its Covid pill reduces risk of hospitalization, death

Pfizer says its new antiviral pill, used with a low-dose HIV drug and taken within three days of symptoms, reduced the risk of hospitalization or death by 89 percent in high-risk adults. The results, which have not been peer reviewed yet, will be submitted to the FDA for emergency use authorization likely before Thanksgiving.Nov. 5, 2021